Myelomonocytic Leukemia
📧 Sign up to get email alerts when something new happens for Myelomonocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial evaluating donor peripheral blood stem cell transplantation in combination with pretargeted radioimmunotherapy for patients wi…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias [Phase 1]
Phase 1 pharmacokinetic study of oral and intravenous clofarabine in high-risk myelodysplastic syndrome and acute leukemias; the trial has c…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Imatinib (Gleevec(Registered Trademark)) to Treat Chronic Myelomonocytic Leukemia and Atypical Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluated imatinib (Gleevec) for chronic myelomonocytic leukemia, chronic myeloid leukemia, and atypical chronic my…
-
CLINICAL_TRIALS trial_result · 2017-06-09Clinical Trial Update: Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat High Risk MDS [Phase 2]
Phase 2 efficacy study evaluating lenalidomide (Revlimid) with low-dose continuous melphalan for high-risk myelodysplastic syndromes, includ…
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia [Phase 1, Phase 2]
This terminated Phase 1/2 trial evaluated low-dose oral clofarabine for IPSS INT-1/INT-2 or high-risk myelodysplastic syndromes and chronic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant [Phase 2]
Phase 2 trial of azacitidine in patients with relapsed myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay [NA]
Clinical trial update on using a high-throughput drug sensitivity assay to guide treatment for relapsed/refractory acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports completion of a study evaluating an investigational biological therapy in adults with advanced mye…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS) [Phase 2]
Phase II trial of a Hedgehog pathway inhibitor in myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) completed with r…
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update of ixazomib in relapsed or refractory acute myeloid leukemia has been terminated; results were posted previous…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes [Phase 2]
Phase 2 clinical trial evaluating imatinib mesylate in patients with various activated tyrosine kinase-driven malignancies, including hypere…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) [Phase 2]
Phase 2 study evaluating imatinib (Gleevec) in patients with myelofibrosis and chronic myelomonocytic leukemia has completed. The study was …
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL [Phase 2]
Phase 2 study evaluating azacitidine with or without birinapant in patients with Myelodysplastic syndrome or Chronic myelomonocytic leukemia…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating a three-drug regimen of omacetaxine mepesuccinate, cytarabine, and decitabine in older adults with newly diagnosed …
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Korean Post-marketing Surveillance for Sprycel®
This is a completed Korean post-marketing surveillance study of Sprycel (dasatinib). It covered patients with chronic myelomonocytic leukemi…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia [Phase 2]
A Phase 2 trial investigates adding lenalidomide or vorinostat to azacitidine in higher-risk myelodysplastic syndromes or chronic myelomonoc…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1]
Phase I study of CWP232291 in patients with acute myeloid leukemia and related myeloid neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia [Phase 1]
Phase 1 study of Terameprocol (EM-1421) in leukemia was terminated; no efficacy results were reported in this update.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Non-interventional Study With Azacitidin (Vidaza®)
This document reports a completed non-interventional study of azacitidine (Vidaza) in patients with myelodysplastic syndromes, acute myeloid…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia [Phase 2]
Phase 2 study evaluating azacitidine (Vidaza) in patients with chronic myelomonocytic leukemia has completed, and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-09-18Clinical Trial Update: Oral Clofarabine Study in Patients With Myelodysplastic Syndrome [Phase 2]
Phase 2 trial of oral clofarabine in patients with myelodysplastic syndrome and chronic myelomonocytic leukemia has completed; results were …
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms [Phase 1]
Termination of a Phase 1 trial evaluating oral azacitidine (CC-486) in Japanese subjects with hematological neoplasms.
-
CLINICAL_TRIALS trial_result · 2015-05-01Clinical Trial Update: Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED) [Phase 3]
Phase 3 trial evaluating lonafarnib versus placebo in patients with myelodysplastic syndromes or chronic myelomonocytic leukemia has been te…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Lenalidomide in Patients With Chronic Myelomonocytic Leukemia [Phase 1, Phase 2]
Clinical trial update indicates ongoing Phase 1 and Phase 2 evaluation of lenalidomide in chronic myelomonocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Aflibercept in Treating Patients With Myelodysplastic Syndromes [Phase 2]
A Phase 2 study of aflibercept in patients with various myelodysplastic syndromes was terminated, with results posted in 2015.